Life Science Company News

Reset
Results 121 - 140 out of 500 displayed.
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

iCAD to Report First Quarter 2024 Financial Results on May 15, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  iCAD, Inc.

Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Science 37, Inc.

Shape Therapeutics Announces Appointment of Matt Valentino as Chief People Officer

Read more ››
By: GlobeNewswire - 02 May 2024

PDS Biotech Appoints Stephan Toutain as Chief Operating Officer

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  PDS Biotechnology Corporation

Intuity Medical’s POGO Automatic®, the First and Only FDA-Cleared Automatic Blood Glucose Monitor, Now Covered by Medicare Part B

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Intuity Medical, Inc

EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  EDAP TMS S.A.

Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Allarity Therapeutics, Inc.

Vicinitas Therapeutics Appoints Adam Hughes as Chief Scientific Officer

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Vicinitas Therapeutics

Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Mersana Therapeutics, Inc.

STALICLA initiates U.S. Phase 3 enabling DDI study of STP7 (Mavoglurant) to treat cocaine use disorder

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Stalicla SA

Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Longeveron Inc.

IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  iRadimed Corporation

Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Wave Life Sciences USA, Inc.

Veru to Present at the GLP-1 Based Therapeutics Summit

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Veru Inc.

Corvus Pharmaceuticals Announces Pricing of $30.6 Million Registered Direct Offering

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Corvus Pharmaceuticals, Inc.

Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Palisade Bio, Inc.

Cerevance Achieves First Milestone in Research Collaboration with Merck

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Cerevance Inc. | Cerevance Inc.

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  GlucoTrack Inc

ASLAN Pharmaceuticals Announces Expansion of its Collaboration With Zenyaku to Investigate the Biology Underlying Differential Effects of Eblasakimab Compared to Other Biologics

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  ASLAN Pharmaceuticals Ltd.

Outlook Therapeutics® to Present at the Retina World Congress 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Outlook Therapeutics, Inc.
Results 121 - 140 out of 500 displayed.
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »